Identification of genes whose expression is altered by obesity throughout the arterial tree

Physiological Genomics

Volumn 46, Issue 22, 2014, Pages 821-832

  Padilla, Jaume ^a,b,c   Jenkins, Nathan T ^d   Thorne, Pamela K ^b   Martin, Jeffrey S ^e   Scott Rector, R ^a,b,f   Wade Davis, J ^b   Harold Laughlin, M ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e QUINNIPIAC UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene expression; Next generation sequencing; OLETF rat model; Resistance arteries; Type 2 diabetes; Vascular dysfunction

Indexed keywords

TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; C2 GENE; CTRB1 GENE; CYP2E1 GENE; DIAPHRAGM MUSCLE; DOWN REGULATION; FAM151B GENE; FOLR2 GENE; GASTROCNEMIUS MUSCLE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GOLGA7 GENE; ILIAC ARTERY; IRF7 GENE; KLRA17 GENE; LGALS3BP GENE; MALE; MEF2BNB GENE; MIS18A GENE; NONHUMAN; OAS1B GENE; OBESITY; PCP4 GENE; PHENOTYPIC VARIATION; PXMP4 GENE; RAD23A GENE; RAT; RIN3 GENE; RNA SEQUENCE; SLC25A44 GENE; SLFN3 GENE; SNX10 GENE; SOLEUS MUSCLE; SREBF2 GENE; UPREGULATION; VASCULAR DISEASE; ANIMAL; ARTERY; BODY WEIGHT; FEEDING BEHAVIOR; GENE REGULATORY NETWORK; GENETICS; METABOLISM; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PATHOLOGY;

RATTUS;

ANIMALS; ARTERIES; BODY WEIGHT; DOWN-REGULATION; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MALE; OBESITY; RATS, INBRED OLETF; UP-REGULATION;

EID: 84910614013     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00091.2014     Document Type: Article

References (46)

1. Abe Ji, Berk BC. Atheroprone flow activation of the sterol regulatory element binding protein 2 and nod-like receptor protein 3 inflammasome mediates focal atherosclerosis. Circulation 128: 579-582, 2013.
2. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640- 1645, 2009.
3. Armstrong RB, Laughlin MH. Blood flows within and among rat muscles as a function of time during high speed treadmill exercise. J Physiol 344: 189-208, 1983.
4. Barlow M, Restaino R. Limb specific comparison of flow-mediated dilation in overweight, pre-menopausal women. FASEB J 28: 2014.
5. Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 56: 369-381, 2014.
6. Bender SB, Newcomer SC, Laughlin MH. Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity. Am J Physiol Heart Circ Physiol 300: H1434-H1441, 2011.
7. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300, 1995.
8. Booth FW, Laye MJ, Lees SJ, Rector RS, Thyfault JP. Reduced physical activity and risk of chronic disease: the biology behind the consequences. Eur J Appl Physiol 102: 381-390, 2008.
9. Booth FW, Lees SJ. Fundamental questions about genes, inactivity, and chronic diseases. Physiol Genomics 28: 146-157, 2007.
10. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic disease. Compreh Physiol 2: 1143-1211, 2012.
11. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037, 2005.
12. Chakravarthy MV, Booth FW. Eating, exercise, and "thrifty" genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 96: 3-10, 2004.
13. Colonne PM, Eremeeva ME, Sahni SK. Beta interferon-mediated activation of signal transducer and activator of transcription protein 1 interferes with rickettsia conorii replication in human endothelial cells. Infect Immun 79: 3733-3743, 2011.
14. de Jonge H, Fehrmann R, de Bont E, Hofstra R, Gerbens F, Kramps W, de Vries E, van der Zee A, te Meerman G, ter Elst A. Evidence based selection of housekeeping genes. PLoS One 2: e898, 2007.
15. Despres J. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 29: 77-82, 2006.
16. Goldstein JL, Brown MS. From fatty streak to fatty liver: 33 years of joint publications in the JCI. J Clin Invest 118: 1220-1222, 2008.
17. Goran M, Ball G, Cruz M. Obesity and risk of Type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 88: 1417-1427, 2003.
18. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131, 2002.
19. Jager NA, Teteloshvili N, Zeebregts CJ, Westra J, Bijl M. Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk? Autoimmun Rev 11: 621-626, 2012.
20. Jahangir E, De Schutter A, Lavie CJ. The relationship between obesity and coronary artery disease. Transl Res [Epub ahead of print].
21. Jenkins NT, Padilla J, Martin JS, Crissey JM, Thyfault JP, Rector R, Laughlin M. Differential vasomotor effects of insulin on gastrocnemius and soleus feed arteries in the OLETF rat model: role of endothelin-1. Exp Physiol 99: 262-271, 2014.
22. Jenkins NT, Padilla J, Thorne P, Martin J, Rector R, Davis J, Laughlin M. Transcriptome-wide RNA sequencing analysis of rat skeletal muscle feed arteries. I. Impact of obesity. J Appl Physiol 116: 1017-1032, 2014.
23. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422- 1428, 1992.
24. Kim Y, Nam YJ, Lee C. Analysis of the SREBF2 gene as a genetic risk factor for vascular dementia. Am J Med Genet B Neuropsychiatr Genet 139B: 19-22, 2005.
25. Lambert E, Straznicky N, Lambert G. A sympathetic view of human obesity. Clin Auton Res 23: 9-14, 2013.
26. Li Y, Xu S, Jiang B, Cohen RA, Zang M. Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs. PLoS One 8: e67532, 2013.
27. Morioka T, Emoto M, Yamazaki Y, Kawano N, Imamura S, Numaguchi R, Urata H, Motoyama K, Mori K, Fukumoto S, Koyama H, Shoji T, Inaba M. Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes. Cardiovas Diabetol 13: 10, 2014.
28. Muller A, Beck K, Rancic Z, Muller C, Fischer C, Betzel T, Kaufmann P, Schibli R, Kramer S, Ametamey S. Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer. Mol Imaging 13: 1-11, 2014.
29. Musso G, Cassader M, Bo S, De Michieli F, Gambino R. Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. Diabetes 62: 1109-1120, 2013.
30. Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res 52: 175- 191, 2013.
31. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in U.S. children and adolescents, 2007-2008. JAMA 303: 242-249, 2010.
32. Padilla J, Jenkins N, Thorne P, Martin J, Rector R, Davis J, Laughlin M. Transcriptome-wide RNA sequencing analysis of rat skeletal muscle feed arteries. II. Impact of exercise training in obesity. J Appl Physiol 116: 1033-1047, 2014.
33. Padilla J, Jenkins NT, Lee S, Zhang H, Cui J, Zuidema MY, Zhang C, Hill MA, Perfield JW 2nd, Ibdah JA, Booth FW, Davis JW, Laughlin MH, Rector RS. Vascular transcriptional alterations produced by juvenile obesity in Ossabaw swine. Physiol Genomics 45: 434-446, 2013.
34. Padilla J, Simmons GH, Davis JW, Whyte JJ, Zderic TW, Hamilton MT, Bowles DK, Laughlin MH. Impact of exercise training on endothelial transcriptional profiles in healthy swine: a genome-wide microarray analysis. Am J Physiol Heart Circ Physiol 301: H555-H564, 2011.
35. Pahan K, Smith BT, Singh AK, Singh I. Cytochrome P-450 2E1 in rat liver peroxisomes: downregulation by ischemia/reperfusion-induced oxidative stress. Free Radic Biol Med 23: 963-971, 1997.
36. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 19: 65-73, 2008.
37. Schäfer A, Galuppo P, Fraccarollo D, Vogt C, Widder JD, Pfrang J, Tas P, Barbosa-Sicard E, Ruetten H, Ertl G, Fleming I, Bauersachs J. Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation. Diabetes 59: 2001-2009, 2010.
38. Shaked I, Hanna DB, Gleißner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, Lazar J, Prasad V, Tien PC, Young MA, Landay AL, Kaplan RC, Ley K. Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol 34: 1085-1092, 2014.
39. Szostak J, Laurant P. The forgotten face of regular physical exercise: a 'natural' anti-atherogenic activity. Clin Sci 121: 91-106, 2011.
40. Van de Voorde J, Pauwels B, Boydens C, Decaluwé K. Adipocytokines in relation to cardiovascular disease. Metabolism 62: 1513-1521, 2013.
41. Vykoukal D, Davies MG. Vascular biology of metabolic syndrome. J Vasc Surg 54: 819-831, 2011.
42. Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, She ZG, Zhang XD, Li H. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 305: E485-E495, 2013.
43. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 16: 2323-2330, 2008.
44. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81: 555-563, 2005.
45. Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC, Marin T, Shentu Tp, Wen L, Gongol B, Sun W, Liang X, Chen J, Huang HD, Pedra JHF, Johnson DA, Shyy JYJ. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic- induced atherosclerosis susceptibility. Circulation 128: 632-642, 2013.
46. Zhang F, Deng H, Kemp R, Singh H, Gopal VR, Falck JR, Laniado- Schwartzman M, Nasjletti A. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats. Hypertension 45: 103-108, 2005.